These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 28062533)
1. BET Bromodomain Proteins as Cancer Therapeutic Targets. Shu S; Polyak K Cold Spring Harb Symp Quant Biol; 2016; 81():123-129. PubMed ID: 28062533 [TBL] [Abstract][Full Text] [Related]
11. A Review of the Bromodomain and Extraterminal Domain Epigenetic Reader Proteins: Function on Virus Infection and Cancer. Wu M; Guan G; Yin H; Niu Q Viruses; 2024 Jul; 16(7):. PubMed ID: 39066258 [TBL] [Abstract][Full Text] [Related]
12. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Shi J; Vakoc CR Mol Cell; 2014 Jun; 54(5):728-36. PubMed ID: 24905006 [TBL] [Abstract][Full Text] [Related]
13. BET Bromodomain as a Target of Epigenetic Therapy. Noguchi-Yachide T Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788 [TBL] [Abstract][Full Text] [Related]
14. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins. Taniguchi Y Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996 [TBL] [Abstract][Full Text] [Related]
15. BET bromodomain inhibitors--a novel epigenetic approach in castration-resistant prostate cancer. Lochrin SE; Price DK; Figg WD Cancer Biol Ther; 2014; 15(12):1583-5. PubMed ID: 25535892 [TBL] [Abstract][Full Text] [Related]
16. BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1. Stewart HJ; Horne GA; Bastow S; Chevassut TJ Cancer Med; 2013 Dec; 2(6):826-35. PubMed ID: 24403256 [TBL] [Abstract][Full Text] [Related]
17. Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor κB (NF-κB) signaling. Wu X; Qi J; Bradner JE; Xiao G; Chen LF J Biol Chem; 2013 Dec; 288(50):36094-105. PubMed ID: 24189064 [TBL] [Abstract][Full Text] [Related]
18. Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma. Markman RL; Webber LP; Nascimento Filho CHV; Reis LA; Vargas PA; Lopes MA; Zanella V; Martins MD; Squarize CH; Castilho RM Cell Oncol (Dordr); 2019 Apr; 42(2):143-155. PubMed ID: 30539410 [TBL] [Abstract][Full Text] [Related]
19. BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cells. Li J; Ma J; Meng G; Lin H; Wu S; Wang J; Luo J; Xu X; Tough D; Lindon M; Rioja I; Zhao J; Mei H; Prinjha R; Zhong Z Stem Cell Res; 2016 Sep; 17(2):212-221. PubMed ID: 27591477 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1. Zhang C; Su ZY; Wang L; Shu L; Yang Y; Guo Y; Pung D; Bountra C; Kong AN Biochem Pharmacol; 2016 Oct; 117():35-45. PubMed ID: 27520485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]